Prevention of RSV Infections in Bone Marrow Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 1999

Study Completion Date

May 31, 2001

Conditions
Respiratory Syncytial Virus Infection
Interventions
DRUG

RSV Polyclonal Immunoglobulin

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH